Cargando…
Heparin: Past, Present, and Future
Heparin, the most widely used anticoagulant drug in the world today, remains an animal-derived product with the attendant risks of adulteration and contamination. A contamination crisis in 2007–2008 increased the impetus to provide non-animal-derived sources of heparin, produced under cGMP condition...
Autores principales: | Oduah, Eziafa I., Linhardt, Robert J., Sharfstein, Susan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039491/ https://www.ncbi.nlm.nih.gov/pubmed/27384570 http://dx.doi.org/10.3390/ph9030038 |
Ejemplares similares
-
Harnessing the vulnerabilities of p53 mutants in lung cancer – Focusing on the proteasome: a new trick for an old foe?
por: Oduah, Eziafa I., et al.
Publicado: (2020) -
The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma—successes and challenges
por: Oduah, Eziafa I., et al.
Publicado: (2022) -
Ketogenic Diet-Induced Severe Ketoacidosis in a Lactating Woman: A Case Report and Review of the Literature
por: Nnodum, Benedicta Nneoma, et al.
Publicado: (2019) -
Stroke: The past, present and future
por: Macrae, I. Mhairi, et al.
Publicado: (2018) -
Hypertrophic Cardiomyopathy—Past, Present and Future
por: Liew, Alphonsus C., et al.
Publicado: (2017)